According to the COSMIN panel, the best design to show this is by testing hypotheses about expected correlations or changes.
To show this, we performed different tests, varying the value of the k2 parameter.
Authors' response: For the final model, we have conducted goodness-of-fit test to show this model fits well enough.
Møller and Cuervo claim to show this by reporting a series of tests of repeatability, but their quoted degrees of freedom are difficult to reconcile with the actual (tiny) number of valid comparisons that can be made.
The test works much like a pregnancy test, with a first line appearing to show the test has worked.
For instance, if an asymptomatic, otherwise healthy, patient comes to me wanting a whole-body CT scan to make sure they do not have something bad hiding inside of them, I would decline and educate him or her that there is no data to show that this test has any significant benefit to offset the potential radiation or other harm and the major medical societies do not recommend this test".
It is easy to show that this test statistic is better than in terms of SNR.
Clinical trials have shown this test to work well in some affected regions, and it is certainly an improvement over conventional testing, which requires the collection of blood samples in the middle of the night when the parasites are at their height.
Data analysis was done using the statistical package Significance Analysis of Microarrays (SAM) [22] in R (http://www.r-project.org) since previous results had shown this test to give valid results [23], [24].
While several studies have shown this test to be accurate in many settings,[1], [2] in December 2005, unusually high rates of false-positive results with the oral fluid-based OraQuick® ADVANCE HIV1/2 test were reported in select cities in the United States.
